Beyond infectious disease, GBP2 demonstrates a context-dependent dual role in cancer—acting as either a tumor suppressor or an oncogene by modulating key signaling pathways including JAK-STAT, Wnt/β-catenin, and PI3K/AKT/mTOR. The gene discussed is MTOR; the disease is neoplasm.